Plain-English translation of NCT07403760 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing catheter ablation—a minimally invasive heart procedure—to see if it can improve quality of life and reduce symptoms in very elderly patients (age 80 and older) with atrial fibrillation, a common irregular heartbeat condition. Half of participants will receive the actual ablation procedure, while the other half will receive a sham (fake) procedure to fairly compare how much of the benefit comes from the treatment itself versus from other factors like attention and expectation.
Atrial fibrillation becomes much more common as people age, and the very elderly often struggle with bothersome symptoms like heart palpitations, shortness of breath, and dizziness. While catheter ablation is used to treat younger patients with this condition, doctors don't have strong evidence about whether this treatment truly improves quality of life in the oldest patients.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either the real ablation procedure or a sham procedure. Both groups will be blinded—meaning you won't know which procedure you received—and will wear eye masks and headphones during the procedure to ensure fairness. Over the following 6 months, you will complete quality-of-life questionnaires and have heart tests (like ultrasounds and blood work) to measure how you're doing and whether your symptoms have improved.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
China